Sabiedrība ar ierobežotu atbildību "Meda Pharma" — Financial statements & reports

Name: Datreal.com Company Registry
Creator: Datreal.com
License: https://opendatacommons.org/licenses/by/1.0/

Income statement

Income statement
Year	Revenue	Inventory changes	Long-term investment expenses	Other operating income (by nature)	Material expenses	Labour expenses	Depreciation	Cost of goods sold	Gross profit	Selling expenses	Administrative expenses	Other operating income (by function)	Other operating expenses	Profit from equity investments	Other long-term investment income	Interest income	Investment revaluation	Interest expenses	Extraordinary income	Extraordinary expenses	Profit before taxes	Income tax provisions	Profit after taxes	Other taxes	Extraordinary dividends	Net profit
2022	10 316 141 €	-	-	-	-	-	-	8 930 017 €	1 386 124 €	312 655 €	567 412 €	0 €	14 946 €	0 €	0 €	0 €	-	27 066 €	-	-	464 045 €	15 €	464 030 €	-	0 €	464 030 €
2021	11 815 382 €	-	-	-	-	-	-	9 770 579 €	2 044 803 €	278 950 €	446 518 €	464 €	17 148 €	0 €	0 €	0 €	-	27 024 €	-	-	1 275 627 €	0 €	1 275 627 €	-	0 €	1 275 627 €

Year	Assets					Assets					Liabilities				Equity		Total liabilities & equity
Year	Cash	Securities	Receivables	Inventories	Total current assets	Investments	Intangible assets	Fixed assets	Total non-current assets	Total assets	Future housing repairs	Current liabilities	Non-current liabilities	Provisions	Capital	Total equity	Total liabilities & equity
2022	4 376 715 €	0 €	3 014 694 €	3 185 318 €	10 576 727 €	0 €	4426 €	142 €	4568 €	10 581 295 €	-	2 145 219 €	0 €	0 €	8 436 076 €	10 581 295 €	10 581 295 €
2021	3 208 339 €	0 €	3 218 427 €	3 474 056 €	9 900 822 €	0 €	4426 €	335 €	4761 €	9 905 583 €	-	1 933 537 €	0 €	0 €	7 972 046 €	9 905 583 €	9 905 583 €

Year	Operating cash flow	Investing cash flow	Financing cash flow	Net cash change
2022	Not available
2021	Not available

Year	Total taxes	Change	Income tax	Social tax	Employees
2022	1 510 460 €	-	85 020 €	124 530 €	6